Arbor Vita Competitors and Similar CompaniesClear all

Arbor Vita's competitors and similar companies include Aspira Women's Health, Provista Diagnostics, OncoTAb and Prosigna.
Arbor Vita
Arbor Vita
Arbor Vita Corporation (AVC) is a biotech company developing cancer diagnostics.
Aspira Women's Health
Aspira Women's Health
Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.
Provista Diagnostics
Provista Diagnostics
Provista Diagnostics is a molecular diagnostics company providing tests to detect women’s cancer.
OncoTAb
OncoTAb
OncoTAb is a biotechnology company engaged in cancer care by addressing unmet cancer diagnostic and therapeutic needs.
Prosigna
Prosigna
Prosigna is a test for breast cancer developed by Veracyte to measure recurrence risk.
Founding Date
Founding Date
1998
Founding Date
1993
Founding Date
2007
Founding Date
2011
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Fremont, US HQ
Locations
Austin, US HQ
Locations
Alpharetta, US HQ
Locations
Charlotte, US HQ
Locations
HQ
Employees
Employees
24
Employees
4310% increase
Employees
9
Employees
3
Employees
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 84.4m
Total funding raised
$ 34.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Aspira Women's Health
HQ
Austin, US
Employees
43↑ 10% increase

Vermillion develops and commercializesdiagnostic teststhat address unmet needs in gynecologic oncology and womens health.

View company
Provista Diagnostics
HQ
Alpharetta, US

Provista Diagnostics is a molecular diagnostics company providing tests to detect women’s cancer.

View company
OncoTAb
HQ
Charlotte, US
Employees
3

OncoTAb is a biotechnology company engaged in cancer care by addressing unmet cancer diagnostic and therapeutic needs.

View company
Prosigna
HQ

Prosigna is a test for breast cancer developed by Veracyte to measure recurrence risk.

View company